Anterior mitral valve leaflet length in cats with hypertrophic cardiomyopathy

J Seo1, J Novo Matos2, J R Payne3

  • 1Animal Referral Centre, Auckland, New Zealand; School of Veterinary Science, Massey University, Palmerston North, New Zealand; Clinical Science and Services, Royal Veterinary College, Hertfordshire, United Kingdom.

Insights

Elongated anterior mitral valve leaflets (AMVL) in cats predict the development of hypertrophic cardiomyopathy (HCM). This finding suggests AMVL length is a valuable early indicator for feline HCM risk assessment.

Area of Science:

  • Cardiology
  • Veterinary Medicine
  • Genetics

Background:

  • Anterior mitral valve leaflet (AMVL) elongation is a known characteristic of hypertrophic cardiomyopathy (HCM).
  • The predictive value of AMVL elongation for the development of left ventricular hypertrophy in cats remains unclear.
  • This study investigated whether AMVL elongation precedes the onset of HCM in feline populations.

Purpose of the Study:

  • To determine if elongated AMVL in cats is a risk factor for developing HCM.
  • To explore the relationship between baseline AMVL length and the subsequent development of HCM phenotype.
  • To identify potential early diagnostic markers for feline hypertrophic cardiomyopathy.

Main Methods:

  • A retrospective longitudinal study involving 55 apparently healthy cats.
  • Baseline echocardiograms were compared with follow-up echocardiograms obtained over one year.
  • Measurements included AMVL length and left atrial/ventricular dimensions.

Main Results:

  • 17 out of 55 cats (30.9%) developed an HCM phenotype during a median follow-up of 5.4 years.
  • Cats that developed HCM had significantly greater baseline AMVL length (P < 0.0001) and left ventricular wall thickness (P = 0.007).
  • Baseline AMVL length and left ventricular wall thickness were independent predictors of HCM development.

Conclusions:

  • Increased AMVL length at baseline is associated with the subsequent development of left ventricular hypertrophy in cats.
  • AMVL length may serve as a crucial indicator in the natural history of feline HCM.
  • Further research is warranted to explore the clinical utility of AMVL measurements in feline HCM.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
94
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
83
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
69
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
66
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
47
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
80